Equity

Quarterly ResultsHome > Equity > Corporate Information > Quarterly Results

Parenteral Drugs (India) LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:524689 NSE Symbol: PDPL P/E (TTM) :0
ISIN Demat:INE904D01019 Div & Yield %:0 EPS (TTM) :0
Book Value (RS) :-300.6045095 Market Cap (Rs Cr.):10.11 Face Value (RS) :10
    Change Company 
Quarters :  
ParticularsMar 2022Dec 2021Sep 2021Jun 2021
 (Rs in Cr)(Rs in Cr)(Rs in Cr)(Rs in Cr)
Gross Sales 1.771.442.352.93
Other Operating Income 0.040.010.010.01
Other Income  52.210.000.000.00
Total Income 54.021.452.362.94
Total Expenditure  7.664.675.625.57
PBIDT 46.37-3.21-3.26-2.62
Interest  0.0036.6835.4734.10
PBDT 46.36-39.90-38.72-36.72
Depreciation 27.154.334.334.33
Tax 0.000.000.000.00
Fringe Benefit Tax 0.000.000.000.00
Deferred Tax -4.60-9.70-9.44-9.02
Reported Profit After Tax 23.81-34.52-33.61-32.04
Extra-ordinary Items  52.210.000.000.00
Adjusted Profit After Extra-ordinary item -28.40-34.52-33.61-32.04
     
EPS (Unit Curr.) 7.99-11.58-11.28-10.74
EPS (Adj) (Unit Curr.) 7.99-11.58-11.28-10.74
Calculated EPS (Unit Curr.) 7.99-11.58-11.27-10.74
Calculated EPS (Adj) (Unit Curr.) 7.99-11.58-11.27-10.74
Calculated EPS (Ann.) (Unit Curr.) 31.95-46.32-45.09-42.98
Calculated EPS (Adj) (Ann.) (Unit Curr.) 31.95-46.32-45.09-42.98
Book Value (Unit Curr.) 0.000.000.000.00
Dividend (%) 0.000.000.000.00
Equity 29.8229.8229.8229.82
Reserve & Surplus 0.000.000.000.00
Face Value 10.0010.0010.0010.00
     
Public Shareholding (No. Of Shares) 0.000.000.000.00
Public Shareholding (% in Equity) 0.000.000.000.00
     
Pledged/Encumbered - No. of Shares 0.000.000.000.00
Pledged/Encumbered - % in Total Promoters Holding 0.000.000.000.00
Pledged/Encumbered - % in Total Equity 0.000.000.000.00
     
Non Encumbered - No. of Shares 0.000.000.000.00
Non Encumbered - % in Total Promoters Holding 0.000.000.000.00
Non Encumbered - % in Total Equity 0.000.000.000.00
     
PBIDTM(%) 2619.77-222.92-138.72-89.42
PBDTM(%) 2619.21-2770.83-1647.66-1253.24
PATM(%) 1345.20-2397.22-1430.21-1093.52

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)